Yonglin Liu, Ph.D., is a member of the IP procurement and portfolio management practice group and USPTO registered.
Yonglin's technical expertise includes pharmaceutical, chemical, materials science and engineering, nanotechnology/nanomaterials, biotechnology, biofuel, and other life science technologies, along with consumer products, water treatment and purification, biomedical and mechanical art. Yonglin has assisted a broad range of clients including universities and research institutes, start-ups, mid-size companies and Fortune 500 multinational corporations. He has assisted clients to secure patents or prosecute patent applications in the fields of pharmaceuticals, small-molecule drugs and related formulations, vaccine technology, catalysts, natural products, polymers, nanomaterials, lubricants, surfactants, recombinant proteins, therapeutic antibodies, medical devices, drug delivery systems, diagnostic systems and others.
Prior to joining the firm, Yonglin served as an associate at an American law firm where he managed and maintained large patent portfolios and counseled clients on patent prosecution and potential infringement risks. He has over eight years of experience on preparing and prosecuting U.S. and international patent applications and assisting clients with patentability analyses and infringement and invalidity assessments. Yonglin is an author of many prestigious publications, including those from Angew. Chem. Int. Ed. and Nano Letter. He is also a named inventor on an issued U.S. patent.
